Kiniksa Pharmaceuticals International, plc
KNSA
$47.02
$0.521.12%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 414.07M | 352.10M | 307.78M | 268.34M | 243.63M |
| Total Receivables | 15.59M | 51.74M | 31.91M | 40.07M | 41.72M |
| Inventory | 54.90M | 41.40M | 48.18M | 22.07M | 26.36M |
| Prepaid Expenses | 42.61M | 30.29M | 32.44M | 25.43M | 20.08M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 527.18M | 475.53M | 420.31M | 355.91M | 331.80M |
|
|
|||||
| Total Current Assets | 527.18M | 475.53M | 420.31M | 355.91M | 331.80M |
| Net Property, Plant & Equipment | 11.75M | 11.73M | 11.38M | 11.06M | 11.04M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 15.25M | 15.50M | 15.75M | 16.00M | 16.25M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 209.46M | 209.58M | 213.71M | 216.36M | 221.47M |
| Total Assets | 763.63M | 712.33M | 661.15M | 599.33M | 580.55M |
|
|
|||||
| Total Accounts Payable | 2.03M | 6.15M | 8.96M | 1.98M | 2.04M |
| Total Accrued Expenses | 112.04M | 94.22M | 88.35M | 75.90M | 80.51M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.99M | 2.70M | 2.52M | 2.29M | 1.99M |
| Total Finance Division Other Current Liabilities | 22.13M | 20.52M | 18.00M | 17.09M | 16.08M |
| Total Other Current Liabilities | 22.13M | 20.52M | 18.00M | 17.09M | 16.08M |
| Total Current Liabilities | 139.18M | 123.59M | 117.83M | 97.27M | 100.62M |
|
|
|||||
| Total Current Liabilities | 139.18M | 123.59M | 117.83M | 97.27M | 100.62M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 6.51M | 7.02M | 7.24M | 7.62M | 7.86M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 50.33M | 46.34M | 41.07M | 36.95M | 33.63M |
| Total Liabilities | 196.03M | 176.95M | 166.14M | 141.84M | 142.12M |
|
|
|||||
| Common Stock & APIC | 1.03B | 1.01B | 989.83M | 970.26M | 959.74M |
| Retained Earnings | -462.14M | -476.34M | -494.77M | -512.60M | -521.14M |
| Treasury Stock & Other | -25.00K | -155.00K | -53.00K | -165.00K | -163.00K |
| Total Common Equity | 567.61M | 535.38M | 495.01M | 457.49M | 438.44M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 567.61M | 535.38M | 495.01M | 457.49M | 438.44M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 567.61M | 535.38M | 495.01M | 457.49M | 438.44M |
|
|
|||||